Atlas Trials

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

Clinical trial NCT02101385 · COMPLETED

Trial details

NCT number
NCT02101385
Sponsor
Bryan Schneider, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Neoplasm of BreastBreast Cancer
Start date
2014-04-03
Primary completion
2021-02-21
Enrollment
193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.